Ventyx Biosciences’ (VTYX) Outperform Rating Reiterated at Oppenheimer
Oppenheimer reissued their outperform rating on shares of Ventyx Biosciences (NASDAQ:VTYX – Free Report) in a research report report published on Friday morning,Benzinga reports. The firm currently has a $9.00 target price on the stock, down from their prior target price of $10.00. VTYX has been the subject of several other reports. Wells Fargo & […]
More Stories
Direxion Daily GOOGL Bear 1X Shares (NASDAQ:GGLS) Short Interest Up 41.7% in October
Direxion Daily GOOGL Bear 1X Shares (NASDAQ:GGLS – Get Free Report) was the recipient of a significant increase in short...
Invesco Real Assets ESG ETF (BATS:IVRA) Plans Dividend of $0.04
Invesco Real Assets ESG ETF (BATS:IVRA – Get Free Report) announced a dividend on Friday, November 15th,NASDAQ Dividends reports. Stockholders...
iShares ESG MSCI USA Leaders ETF (NASDAQ:SUSL) Sees Significant Decline in Short Interest
iShares ESG MSCI USA Leaders ETF (NASDAQ:SUSL – Get Free Report) was the recipient of a significant decline in short...
Society Pass Incorporated (NASDAQ:SOPA) Sees Large Increase in Short Interest
Society Pass Incorporated (NASDAQ:SOPA – Get Free Report) was the recipient of a significant growth in short interest in the...
Short Interest in First Trust Cloud Computing ETF (NASDAQ:SKYY) Declines By 18.1%
First Trust Cloud Computing ETF (NASDAQ:SKYY – Get Free Report) was the target of a significant drop in short interest...
Imunon, Inc. (NASDAQ:IMNN) Short Interest Update
Imunon, Inc. (NASDAQ:IMNN – Get Free Report) was the recipient of a significant growth in short interest in the month...